Blog
EQS-News: Branicks Group AG: Fully on track with sales and financial consolidation
EQS-News: Branicks Group AG: Fully on track with sales and financial consolidation
EQS-News: YOC AG: Significant Profitability Increase According to Preliminary Figures in the First Half of 2024
EQS-News: YOC AG: Significant Profitability Increase According to Preliminary Figures in the First Half of 2024
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
EQS-News: Semperit finalizes sale of the remaining medical business
EQS-News: Semperit finalizes sale of the remaining medical business
Petrofac Limited: Petrofac extends forebearance agreement with ad hoc group of noteholders
Petrofac Limited: Petrofac extends forebearance agreement with ad hoc group of noteholders
EQS-News: DEFENCE’S ACCUTOX BOOSTS AND SYNERGIZES WITH IMMUNE CHECKPOINT INHIBITORS
EQS-News: DEFENCE’S ACCUTOX BOOSTS AND SYNERGIZES WITH IMMUNE CHECKPOINT INHIBITORS
Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization
Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization
EQS-News: Eighth and largest acquisition in 2024: Mutares has signed an agreement to acquire Serneke Sverige from Serneke Group
EQS-News: Eighth and largest acquisition in 2024: Mutares has signed an agreement to acquire Serneke Sverige from Serneke Group
EQS-News: Nordex Group receives order from Spain for almost 124 MW
EQS-News: Nordex Group receives order from Spain for almost 124 MW
Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand
Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand
EQS-News: VIB Vermögen AG realizes value
EQS-News: VIB Vermögen AG realizes value
Aperam update on Q2 2024 market & financial trends
Aperam update on Q2 2024 market & financial trends
EQS-News: Formycon receives FDA approval for FYB203/AHZANTIVE®1) (aflibercept-mrbb), a biosimilar to Eylea®2)
EQS-News: Formycon receives FDA approval for FYB203/AHZANTIVE®1) (aflibercept-mrbb), a biosimilar to Eylea®2)
Silvio Denz publishes provisional interim result of the public tender offer to public shareholders of Lalique Group
Silvio Denz publishes provisional interim result of the public tender offer to public shareholders of Lalique Group
Acquisition Dejond Fastening NV
Acquisition Dejond Fastening NV
EQS-Adhoc: Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
EQS-Adhoc: Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
EQS-News: Endor AG makes progress in reorganizing the company in terms of management and financing
EQS-News: Endor AG makes progress in reorganizing the company in terms of management and financing
EQS-Adhoc: FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb)
EQS-Adhoc: FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb)
EQS-News: The NAGA Group AG publishes 2023 Annual Report – 2024 Capital Markets Day in the wake of the merger with CAPEX.com
EQS-News: The NAGA Group AG publishes 2023 Annual Report – 2024 Capital Markets Day in the wake of the merger with CAPEX.com
EQS-Adhoc: clearvise AG: Tion Renewables AG owns more than 25% of the shares
EQS-Adhoc: clearvise AG: Tion Renewables AG owns more than 25% of the shares
EQS-News: TTL publishes Annual Report 2023
EQS-News: TTL publishes Annual Report 2023
EQS-Adhoc: STRABAG SE shareholder MKAO Rasperia Trading Ltd. now also on EU sanctions list
EQS-Adhoc: STRABAG SE shareholder MKAO Rasperia Trading Ltd. now also on EU sanctions list
EQS-Adhoc: Endor AG: Extension of the standstill agreement by lending banks as part of the StaRUG proceedings
EQS-Adhoc: Endor AG: Extension of the standstill agreement by lending banks as part of the StaRUG proceedings
Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc: POS-Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares


